Collectively, this study reveals a novel mechanism responsible for IFN-γ-induced NF-κB activation and suggests that the NF-κB pathway is involved in modulating the response of oligodendrocytes to IFN-γ in immune-mediated demyelinating diseases. This evidence concerns the gene NFKB1 and demyelinating disease.